TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Sino Swed Biotech AB
Closing information (x1000 SEK)
| Closing information | 2025/04 | 2024/04 | 2023/04 |
| Turnover |
1,003
|
1,669
|
1,511 |
| Financial expenses |
0
|
2
|
2 |
| Earnings before taxes |
-43
|
483
|
354 |
| EBITDA |
-43
|
484
|
356 |
| Total assets |
513
|
928
|
780 |
| Current assets |
406
|
928
|
780 |
| Current liabilities |
-56
|
5
|
61 |
| Equity capital |
489
|
804
|
627 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Solvency |
95.3%
|
86.6%
|
80.4% |
| Turnover per employee |
502
|
834
|
756 |
| Profit as a percentage of turnover |
-4.3%
|
28.9%
|
23.4% |
| Return on assets (ROA) |
-8.4%
|
52.3%
|
45.6% |
| Current ratio |
-725.0%
|
18560.0%
|
1278.7% |
| Return on equity (ROE) |
-8.8%
|
60.1%
|
56.5% |
| Change turnover |
-666
|
158
|
-169 |
| Change turnover % |
-40%
|
10%
|
-10% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.